Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Allarity Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 10 | 6 | −4 |
| Shares | 145.1K | 2.70K | −142.4K (−98.1%) |
| Value | $42.0K | $4.05K | −$38.0K (−90.4%) |
New holders (1)
Institutions that held Allarity Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 1,274 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Allarity Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Renaissance Technologies LLC | 38,786 | $11.0K |
| Geode Capital Management, LLC | 29,433 | $8.00K |
| Bridgeway Capital Management, LLC | 20,000 | $5.88K |
| State Street Corp | 12,974 | $3.81K |
| Two Sigma Securities, LLC | 12,534 | $3.68K |